drug

Pharmaceutical giant Genzyme withdraws MS drug in order to re-brand it and sell at 20 times the original price

Thursday, October 18, 2012 by: Ethan A. Huff, staff writer
Tags: Genzyme, MS drugs, profiteering

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
White House admits staging fake vaccination operation to gather DNA from the public
Why does the CDC own a patent on Ebola 'invention?'
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
BREAKING: CDC whistleblower confesses to MMR vaccine research fraud in historic public statement
Delicious
(NaturalNews) Thousands of British patients suffering from the devastating chronic inflammatory disease known as multiple sclerosis (MS) now have one fewer conventional treatment option at their disposal thanks to the merciless greed of the Sanofi-owned pharmaceutical giant Genzyme. The U.K.'s Independent reports that Genzyme has intentionally withdrawn a popular MS drug known as alemtuzumab in order to re-brand it and sell it for up to 20 times its current price.

The drug, known as alemtuzumab, has been specifically licensed for the treatment of leukemia. But because it also apparently works quite well at alleviating MS symptoms in many patients, alemtuzumab is the drug of choice for many doctors successfully treating the condition. A study presented at the 64th Annual Meeting of the American Academy of Neurology back in April found that alemtuzumab actually works better than most of the other available drugs specifically approved as treatments for MS. (http://www.medicalnewstoday.com/articles/244718.php)

Just like in the U.S., off-label drug prescriptions are technically legal, which is why many doctors have chosen alemtuzumab over its various alternatives. But Genzyme, in a bid to significantly boost its profits, has decided to pull alemtuzumab from the market in order to run it through new clinical trials, and eventually re-brand it as "Lemtrada," which is expected to cost many thousands of dollars more than currently-available alemtuzumab.

"Many of us think [alemtuzumab] is the best drug for patients with aggressive MS in the early stages of the disease," says Professor John Zajicek from the University of Plymouth, one of many who is calling on the U.K. Health Secretary to stop Genzyme from restricting the drug's use. "It's the greedy behavior of the drug company that upsets me. They are just trying to re-brand it and put the price up. It is morally corrupt."

Genzyme's greed could end up needlessly killing thousands of MS patients

As a result of Genzyme's decision, alemtuzumab will now only be available as a treatment for leukemia patients, and not for MS patients. This is particularly concerning to Zajicek and many others who recognize that thousands MS patients currently rely on alemtuzumab for relief. Many people are questioning how Genzyme could be so heartless that it would pull a vital drug from the market, leaving thousands of patients without treatment.

"There is no good reason why people with MS who have been allowed to benefit from the treatment should now be denied it," Doug Brown, Head of Biomedical Research at the Multiple Sclerosis Society, is quoted as saying by the Independent. "Genzyme needs to come up with a scheme, quickly, that makes their product available to all those people currently being treated and, if it's licensed, price the drug reasonably so it is deemed cost effective on the NHS (National Health Service)."

Since MS is a chronic inflammatory disease, there are also a number of natural remedies that may help quell this serious disease and provide lasting relief without the need for pharmaceutical drugs. Here is a great article by our own Dr. David Jockers that explains some natural strategies for beating MS: http://www.naturalnews.com

Sources for this article include:

http://www.independent.co.uk

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.